Novo Nordisk Adr (NVO)

Dec 10, 2025

Warning: This Skyrocketing Stock Has a Hidden Risk - The Motley Fool

Dec 10, 2025

Dec 10, 2025

Argus Downgrades Novo Nordisk A/S (NVO) to Hold From Buy - Finviz

Dec 10, 2025

Dec 10, 2025

Analysts See Upside In Novo Nordisk A/S (NVO) Driven By Diabetes And Obesity Trends - Finviz

Dec 10, 2025

Dec 08, 2025

Why Novo Nordisk Stock Was Melting on Monday - Finviz

Dec 08, 2025

Dec 04, 2025

Novo Nordisk A/S (NVO): A Bull Case Theory - Finviz

Dec 04, 2025

Dec 01, 2025

Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know. - Finviz

Dec 01, 2025

Nov 29, 2025

Why Novo Nordisk Stock Just Hit a 4-Year Low - Finviz

Nov 29, 2025

Nov 27, 2025

Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - Finviz

Nov 27, 2025

Nov 27, 2025

J.P. Morgan Reiterates a Buy Rating on ​Novo Nordisk (NVO) - Finviz

Nov 27, 2025

Nov 26, 2025

Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B - TradingView

Nov 26, 2025

Nov 26, 2025

European Drugmakers And Banks Put ADRs In The Green - Finimize

Nov 26, 2025

Nov 26, 2025

NVONovo Nordisk ADR Earnings - Finviz

Nov 26, 2025

Nov 26, 2025

Novo Nordisk Wants FDA Nod For A Higher-Dose Wegovy - Sahm

Nov 26, 2025

Nov 26, 2025

Medicare Announces Price Cuts For 15 Drugs— Novo Nordisk's Wegovy And Ozempic To Cost $274 A Month - Sahm

Nov 26, 2025

Nov 26, 2025

Did Pfizer Just Say "Checkmate" to Novo Nordisk? - Finviz

Nov 26, 2025

Nov 25, 2025

Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says - Sahm

Nov 25, 2025

Nov 25, 2025

European ADRs Stay Put As Novo Nordisk Slides - Finimize

Nov 25, 2025

Nov 25, 2025

Novo Nordisk Signals 2026 Push After Amycretin Posts Major Phase 2 Gains In Type 2 Diabetes Patients - Sahm

Nov 25, 2025

Nov 25, 2025

Novo Nordisk (NVO) is Trending On RedditHere's Why - Finviz

Nov 25, 2025

Nov 25, 2025

Novo Nordisk's Wegovy Shows Weight Loss-Independent Liver Benefits in MASH Trial Data - Finviz

Nov 25, 2025

Nov 25, 2025

Here's Why Novo Nordisk Stock Popped Today - Finviz

Nov 25, 2025

Nov 24, 2025

Why Novo Nordisk Stock Sank 5.6% Today - Finviz

Nov 24, 2025

Nov 24, 2025

Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Sahm

Nov 24, 2025

Nov 24, 2025

Novo Nordisk Stock Plunges After Alzheimer’s Drug Failure: NVO Price, News and Outlook Today (24 November 2025) - ts2.tech

Nov 24, 2025

Nov 24, 2025

Novo Nordisk's Blockbuster Weight-Loss Drug Flops In Alzheimer's Trial - Sahm

Nov 24, 2025

Nov 23, 2025

Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? - Finviz

Nov 23, 2025

Nov 21, 2025

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates - ts2.tech

Nov 21, 2025

Nov 21, 2025

Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's - Sahm

Nov 21, 2025

Nov 20, 2025

Novo Nordisk Stock Today (November 20, 2025): Wegovy Price Cuts, Alzheimer’s ‘Lottery Ticket’ Trials and Denmark GDP Put NVO Back in the Spotlight - ts2.tech

Nov 20, 2025

Nov 19, 2025

Berenberg Lowers Novo Nordisk (NVO) Price Target to DKK 400, Maintains Buy Rating - Finviz

Nov 19, 2025

Nov 19, 2025

Down 45% Year-to-Date, Novo Nordisk Ignites a Price War - Finviz

Nov 19, 2025

Nov 19, 2025

Novo Nordisk (NVO) To Lower US Prices of its Injectable Wegovy Obesity Drug - Finviz

Nov 19, 2025